CESX yields 666666.67% · PFE yields 6.20%● Live data
📍 CESX pulled ahead of the other in Year 1
Combined, CESX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CESX + PFE for your $10,000?
CES Synergies, Inc., an asbestos and lead abatement contracting firm, engages in the removal of asbestos and lead from buildings and other structures, and demolition of structures in the United States. It operates through three segments: Remediation, Demolition, and Insulation. The Remediation segment engages in the asbestos abatement, lead removal, mold remediation, and indoor air quality/duct cleaning activities; and removal of contaminated soil, animal waste removal, manual selective and complete interior demolition comprising removal of floor covering, and adhesive removal services for commercial, retail, governmental, industrial, military, and public and private schools. The Demolition segment is involved in the building separations, concrete breaking, and saw-cutting using its own man-lifts, bobcats, roll-off containers, and roll-off trucks for the hauling and disposal of construction debris. This segment also offers full-scale commercial demolition and wrecking, as well as underground and above ground storage tank removal, and full-scale site clearing, including underground pipe removal and installation. The Insulation segment engages in the re-insulation and insulation of new and remodeling projects. CES Synergies, Inc. is also involved in the construction, installation, and repair of ceilings. The company serves city, state, and federal agencies, as well as general contractors, developers, project owners, and industrial and commercial clients. CES Synergies, Inc. was founded in 1988 and is headquartered in Crystal Springs, Florida.
Full CESX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.